These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 16856436
21. Open-label use of placebos in the treatment of ADHD: a pilot study. Sandler AD, Bodfish JW. Child Care Health Dev; 2008 Jan; 34(1):104-10. PubMed ID: 18171451 [Abstract] [Full Text] [Related]
23. Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. Childress AC. Adv Ther; 2012 May; 29(5):385-400. PubMed ID: 22610723 [Abstract] [Full Text] [Related]
24. Tics and psychiatric comorbidity in children and adolescents. Gadow KD, Nolan EE, Sprafkin J, Schwartz J. Dev Med Child Neurol; 2002 May; 44(5):330-8. PubMed ID: 12033719 [Abstract] [Full Text] [Related]
26. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. Amiri S, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Kahbazi M, Akhondzadeh S. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):145-9. PubMed ID: 17765380 [Abstract] [Full Text] [Related]
27. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD. Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schneider J. J Child Neurol; 2008 Sep 01; 23(9):981-90. PubMed ID: 18474932 [Abstract] [Full Text] [Related]
28. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults. Swearingen D, Pennick M, Shojaei A, Lyne A, Fiske K. Clin Ther; 2007 Apr 01; 29(4):617-25. PubMed ID: 17617285 [Abstract] [Full Text] [Related]
32. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children]. Escobar R, Hervas A, Soutullo C, Mardomingo MJ, Uruñuela A, Gilaberte I. Actas Esp Psiquiatr; 2008 Apr 01; 36(5):285-94. PubMed ID: 18830848 [Abstract] [Full Text] [Related]
33. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. Steingard R, Biederman J, Spencer T, Wilens T, Gonzalez A. J Am Acad Child Adolesc Psychiatry; 1993 Mar 01; 32(2):350-3. PubMed ID: 8444764 [Abstract] [Full Text] [Related]
35. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T. J Clin Psychopharmacol; 2009 Jun 01; 29(3):239-47. PubMed ID: 19440077 [Abstract] [Full Text] [Related]
36. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, Deldar A, Schuh K, Durell T. Depress Anxiety; 2009 Jun 01; 26(3):212-21. PubMed ID: 19194995 [Abstract] [Full Text] [Related]
37. Guanfacine use in children with attention deficit hyperactivity disorder. Cohn LM, Caliendo GC. Ann Pharmacother; 1997 Jun 01; 31(7-8):918-9. PubMed ID: 9220058 [Abstract] [Full Text] [Related]